منابع مشابه
juxtapapillary retinal capillary hemangioma: new therapeutic strategies
the treatment of juxtapapillary retinal capillary hemangiomas (jrchs) is still a therapeutic dilemma without established guidelines. because of the location of these hemangiomas on or adjacent to the optic nerve, treatment is difficult and complex, especially when jrchs are located in the papillomacular bundle. this manuscript reviews the clinically relevant data on literature regarding the tre...
متن کاملNew therapeutic strategies for raltegravir.
Raltegravir (Isentress) is the first approved HIV integrase inhibitor. Agents in this class target a different viral enzyme compared with agents inhibiting reverse transcriptase and protease. A wide number of patients are currently susceptible to integrase inhibitors, including heavily antiretroviral-experienced patients harbouring drug-resistant viruses. The good tolerability and convenience o...
متن کاملNew therapeutic strategies in treating the new Coronavirus 2019: review article
The highly contagious new coronavirus virus, SARS-CoV-2, was first appeared in Wuhan, China in late 2019. The virus has spread to 216 countries, including Iran, until 7 September 2020. So far, the number of people infected by the new corona virus and died from the disease is 27032617 and 881464 worldwide, respectively. Therefore, it is necessary to introduce the available treatments for this vi...
متن کاملAtrial fibrillation and new therapeutic strategies.
When new therapy challenges a critical disease the clinical spectrum is changed. But although the implantable cardioverter defibrillator is at the forefront of ventricular arrhythmia treatment, the number of implantations per million population remains limited (Fig. 1). The reasons for this poor take up must be one of costs set against the benefits, and indeed, the implantable cardioverter defi...
متن کاملPeripheral T-cell lymphoma: new therapeutic strategies.
Between 2006 and 2011, four new agents gained regulatory approval for the treatment of relapsed/refractory cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). These new approvals, together with recent advances in both combination chemotherapy and transplant strategies, have made the landscape for treatment of these patients immensely complex. Multiple clinical trials are now...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Parasite
سال: 2008
ISSN: 1252-607X,1776-1042
DOI: 10.1051/parasite/2008153522